Bioequivalence test for non-lognormally distributed data

碩士 === 國立中央大學 === 統計研究所 === 100 === In a pharmacokinetic (PK) study, to claim a test drug under study as a generic drug, proof of the bioequivalence between the test drug and a comparative reference drug is needed. To do so, some healthy volunteers are recruited and administered with the two drugs...

Full description

Bibliographic Details
Main Authors: Kuo-sung Chan, 詹國松
Other Authors: Yuh-ing Chen
Format: Others
Language:zh-TW
Published: 2012
Online Access:http://ndltd.ncl.edu.tw/handle/08410381959145479901
id ndltd-TW-100NCU05337020
record_format oai_dc
spelling ndltd-TW-100NCU053370202015-10-13T21:22:37Z http://ndltd.ncl.edu.tw/handle/08410381959145479901 Bioequivalence test for non-lognormally distributed data 針對非對數常態資料的生體相等性檢定 Kuo-sung Chan 詹國松 碩士 國立中央大學 統計研究所 100 In a pharmacokinetic (PK) study, to claim a test drug under study as a generic drug, proof of the bioequivalence between the test drug and a comparative reference drug is needed. To do so, some healthy volunteers are recruited and administered with the two drugs in a 2×2 crossover design with a reasonable wash-out time period, where the volunteers in one sequence receive the reference drug and then the test drug in two different periods, while the volunteers in the other sequence take the drugs in reverse order in the two periods. After the drug is administered to each volunteer, the drug concentrations in blood or plasma at different time points are then measured, which is referred to as the drug concentration–time curve or profile. The average bioavailability parameters such as the area under the drug concentration–time curve (AUC) is conventionally of interest for assessing the bioequivalence of the test drug to the reference drug. Conventionally, however, the distribution of the logarithm of individual AUC (denoted by logAUC) is followed the lognormal distribution. In practice, this assumption is violated and hence, in this thesis, we propose an alternative distribution, inverse gamma distribution, to satisfy the assumption of the distribution of individual logAUC. In this thesis, we consider to construct the model of individual logAUC which has subject variation and the error term are distributed by normal distribution and inverse gamma distribution, respectively, under the 2x2 crossover design. We consider using the stochastic approximation expectation- maximization algorithm to find the maximum likelihood estimates of the parameters. Then, the bioequivalence test of two drugs is inducted by estimated mean AUC. We further present some results of a simulation study investigation of the level and power performances of the purposed method and the application of the proposed test is finally illustrated by using a real data. Yuh-ing Chen 陳玉英 2012 學位論文 ; thesis 35 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立中央大學 === 統計研究所 === 100 === In a pharmacokinetic (PK) study, to claim a test drug under study as a generic drug, proof of the bioequivalence between the test drug and a comparative reference drug is needed. To do so, some healthy volunteers are recruited and administered with the two drugs in a 2×2 crossover design with a reasonable wash-out time period, where the volunteers in one sequence receive the reference drug and then the test drug in two different periods, while the volunteers in the other sequence take the drugs in reverse order in the two periods. After the drug is administered to each volunteer, the drug concentrations in blood or plasma at different time points are then measured, which is referred to as the drug concentration–time curve or profile. The average bioavailability parameters such as the area under the drug concentration–time curve (AUC) is conventionally of interest for assessing the bioequivalence of the test drug to the reference drug. Conventionally, however, the distribution of the logarithm of individual AUC (denoted by logAUC) is followed the lognormal distribution. In practice, this assumption is violated and hence, in this thesis, we propose an alternative distribution, inverse gamma distribution, to satisfy the assumption of the distribution of individual logAUC. In this thesis, we consider to construct the model of individual logAUC which has subject variation and the error term are distributed by normal distribution and inverse gamma distribution, respectively, under the 2x2 crossover design. We consider using the stochastic approximation expectation- maximization algorithm to find the maximum likelihood estimates of the parameters. Then, the bioequivalence test of two drugs is inducted by estimated mean AUC. We further present some results of a simulation study investigation of the level and power performances of the purposed method and the application of the proposed test is finally illustrated by using a real data.
author2 Yuh-ing Chen
author_facet Yuh-ing Chen
Kuo-sung Chan
詹國松
author Kuo-sung Chan
詹國松
spellingShingle Kuo-sung Chan
詹國松
Bioequivalence test for non-lognormally distributed data
author_sort Kuo-sung Chan
title Bioequivalence test for non-lognormally distributed data
title_short Bioequivalence test for non-lognormally distributed data
title_full Bioequivalence test for non-lognormally distributed data
title_fullStr Bioequivalence test for non-lognormally distributed data
title_full_unstemmed Bioequivalence test for non-lognormally distributed data
title_sort bioequivalence test for non-lognormally distributed data
publishDate 2012
url http://ndltd.ncl.edu.tw/handle/08410381959145479901
work_keys_str_mv AT kuosungchan bioequivalencetestfornonlognormallydistributeddata
AT zhānguósōng bioequivalencetestfornonlognormallydistributeddata
AT kuosungchan zhēnduìfēiduìshùchángtàizīliàodeshēngtǐxiāngděngxìngjiǎndìng
AT zhānguósōng zhēnduìfēiduìshùchángtàizīliàodeshēngtǐxiāngděngxìngjiǎndìng
_version_ 1718061140693483520